These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1892359)

  • 1. Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease.
    Saper CB; Sorrentino DM; German DC; de Lacalle S
    Ann Neurol; 1991 Jun; 29(6):577-84. PubMed ID: 1892359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease.
    Gai WP; Geffen LB; Denoroy L; Blessing WW
    Ann Neurol; 1993 Apr; 33(4):357-67. PubMed ID: 8489206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y-immunoreactive perikarya and nerve terminals in the rat medulla oblongata: relationship to cytoarchitecture and catecholaminergic cell groups.
    Härfstrand A; Fuxe K; Terenius L; Kalia M
    J Comp Neurol; 1987 Jun; 260(1):20-35. PubMed ID: 2885349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease.
    Matzuk MM; Saper CB
    Ann Neurol; 1985 Nov; 18(5):552-5. PubMed ID: 4073850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromelanin and Parkinson's disease.
    Marsden CD
    J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.
    Malessa S; Hirsch EC; Cervera P; Duyckaerts C; Agid Y
    Neurology; 1990 Nov; 40(11):1739-43. PubMed ID: 1978260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of neurons containing phenylethanolamine N-methyltransferase in medulla and hypothalamus of rat.
    Ruggiero DA; Ross CA; Anwar M; Park DH; Joh TH; Reis DJ
    J Comp Neurol; 1985 Sep; 239(2):127-54. PubMed ID: 2864362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E; Graybiel AM; Agid YA
    Nature; 1988 Jul; 334(6180):345-8. PubMed ID: 2899295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholaminergic systems in the zebrafish. III. Organization and projection pattern of medullary dopaminergic and noradrenergic neurons.
    Ma PM
    J Comp Neurol; 1997 May; 381(4):411-27. PubMed ID: 9136799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholaminergic neurons in the ventrolateral medulla and nucleus of the solitary tract in the human.
    Arango V; Ruggiero DA; Callaway JL; Anwar M; Mann JJ; Reis DJ
    J Comp Neurol; 1988 Jul; 273(2):224-40. PubMed ID: 2901439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Low PA; Parisi JE
    Brain; 2003 Oct; 126(Pt 10):2183-90. PubMed ID: 12902309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat medulla oblongata. IV. Topographical distribution of catecholaminergic neurons with quantitative three-dimensional computer reconstruction.
    Kalia M; Woodward DJ; Smith WK; Fuxe K
    J Comp Neurol; 1985 Mar; 233(3):350-64. PubMed ID: 2858499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure.
    Benarroch EE; Smithson IL; Low PA; Parisi JE
    Ann Neurol; 1998 Feb; 43(2):156-63. PubMed ID: 9485056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis.
    Kato S; Oda M; Hayashi H; Shimizu T; Hayashi M; Kawata A; Tanabe H
    J Neurol Sci; 1995 Oct; 132(2):216-21. PubMed ID: 8543951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of tyrosine hydroxylase and neuropeptide Y-like immunoreactive neurons in rabbit medulla oblongata, with attention to colocalization studies, presumptive adrenaline-synthesizing perikarya, and vagal preganglionic cells.
    Blessing WW; Howe PR; Joh TH; Oliver JR; Willoughby JO
    J Comp Neurol; 1986 Jun; 248(2):285-300. PubMed ID: 2424947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease.
    Goto S; Hirano A
    Ann Neurol; 1991 Aug; 30(2):192-6. PubMed ID: 1680303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death.
    Tada M; Kakita A; Toyoshima Y; Onodera O; Ozawa T; Morita T; Nishizawa M; Takahashi H
    Brain; 2009 Jul; 132(Pt 7):1810-9. PubMed ID: 19429902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL
    Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.